Ubs Group Ag Forward Pharma A/S Transaction History

Ubs Group Ag

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	BUY	$3.25 - $4.65 $7,010 - $10,030	2,157 New	2,157 $6,000
Q1 2022 May 16, 2022	SELL	$5.06 - $6.15 $6,254 - $7,601	-1,236 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$5.43 - $7.01 $6,711 - $8,664	1,236 New	1,236 $7,000
Q2 2021 Aug 13, 2021	SELL	$6.77 - $8.6 $4,055 - $5,151	-599 Closed	0 $0
Q1 2021 May 12, 2021	BUY	$6.51 - $9.0 $3,248 - $4,491	499 Added 499.0%	599 $4,000
Q4 2020 Feb 11, 2021	SELL	$6.22 - $7.4 $1,586 - $1,887	-255 Reduced 71.83%	100 $1,000
Q3 2020 Nov 12, 2020	SELL	$5.99 - $6.78 $569 - $644	-95 Reduced 21.11%	355 $2,000
Q2 2020 Jul 31, 2020	SELL	$5.16 - $7.77 $4,881 - $7,350	-946 Reduced 67.77%	450 $3,000
Q1 2020 May 01, 2020	BUY	$4.92 - $7.7 $3,183 - $4,981	647 Added 86.38%	1,396 $8,000
Q4 2019 Feb 14, 2020	BUY	$5.65 - $9.6 $4,231 - $7,190	749 New	749 $5,000

Ticker FWP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 7,091,180
Market Cap $18.2M
Description
Forward Pharma A/S does not have significant operations. Previously, it operated as a biopharmaceutical company that focused on developing FP187 proprietary formulation of dimethyl fumarate for the treatment of inflammatory and neurological indications. Forward Pharma A/S was incorporated in 2005 and is headquartered in Copenhagen, Denmark.

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.